These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6444707)

  • 21. Suppression of murine immunologic functions by fresh and cultured human tumor extracts.
    Davidson DD; Carney DN; Putnam JB; Sugarbaker PH; Roth JA
    J Surg Res; 1985 Mar; 38(3):289-97. PubMed ID: 2984465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocompetence of murine placental lymphocytes. In-vitro response to mitogens and to allogeneic cells.
    Pavia CS; Stites DP
    Immunobiology; 1981; 160(2):228-40. PubMed ID: 6459286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of interleukin-1 on the in vitro PHA-stimulated lymphocytes of some blood donors.
    Olinescu A; Hristescu S; Manda G; Agache F; Neagu M
    Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):289-97. PubMed ID: 3266990
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells.
    Stallcup KC; Liu YN; Dorf ME; Mescher MF
    J Immunol; 1986 Apr; 136(8):2723-8. PubMed ID: 3958487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of levamisole on normal and malignant murine lymphocytes.
    Gordon WC; Prager MD
    J Natl Cancer Inst; 1978 Aug; 61(2):415-21. PubMed ID: 277729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of murine thymocytes in vivo. Part II: Study of blastogenesis, the synthesis of macromolecules and the cytotoxic response after stimulation with phytohemagglutinin.
    Chaudhuri TK; Chakravarty AK
    Lymphology; 1986 Sep; 19(3):117-24. PubMed ID: 2431234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic aspects of concomitant resistance induced by nonimmunogenic murine tumors.
    Meiss RP; Bonfil RD; Ruggiero RA; Pasqualini CD
    J Natl Cancer Inst; 1986 Jun; 76(6):1163-75. PubMed ID: 3458952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of DNA synthesis in normal, but not neoplastic, nuclei by cytoplasmic extracts from resting cells.
    Gutowski JK; Cohen S
    Cell Immunol; 1987 Apr; 106(1):174-9. PubMed ID: 3568145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L; Nusair S; Reich S; Sidi H; Slavin S
    Cancer Immunol Immunother; 1996 Oct; 43(2):103-8. PubMed ID: 8954144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression associated with SJL/J murine lymphoma. II. Characterization of a plasma suppressor factor in tumor-bearing mice.
    Kumar RK; Lykke AW; Penny R
    J Natl Cancer Inst; 1981 Dec; 67(6):1277-82. PubMed ID: 6947110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin.
    Ralph P
    J Immunol; 1973 Jun; 110(6):1470-5. PubMed ID: 4541304
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
    Kumar RK; Lykke AW; Penny R
    J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
    Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
    Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 39. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
    Rumi L; Colmerauer ME; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
    Barry RA; Hinrichs DJ
    Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.